Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Immunscape AB
AB
In liquidation
Org 5590700612
Umeå
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Immunscape AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (5)
EJ
Emma Johanna Åström
External Signatory
External Signatory
2026
SM
Sofie Margareta Lundberg
External Signatory
External Signatory
2026
EF
Emma Frida Ramona Melander Vängbo
External Signatory
External Signatory
2026
MV
Mona Veronica Vesterberg
Liquidator
Liquidator
2026
AB
Anna Birgitta Emanuelsson
External Signatory
External Signatory
2026
Former (4)
DA
David Allan Mathias Färnegårdh
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022 – 2026
LO
Lars Ole Öhman
Chief Executive Officer
Chief Executive Officer
2022 – 2026
AE
Anna Elisabeth Adolfsson
Liquidator
Liquidator
2026 – 2026
RA
Roger Andreas Ehrman
Audit
Audit
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
KF
Konrad Forster Koehler
Chairman
Chairman
2022 – 2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Immunscape AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
